UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

496a - Serum IL-2 and IL-8 are Elevated within 4 h after Gluten Ingestion in Celiac Disease (CED) Patients on Gluten-Free Diet (GFD) and Potential to Resolve Indeterminate Diagnoses for Patients on GFD

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S114-S114

2017

Volltextzugriff (PDF)

846 Efficacy, Safety, Tolerability, and Immunological Effects of Nexvax2®, a Peptide-Based Therapeutic Vaccine, Administered by Intra-Dermal (ID) Injection Twice-Weekly for 8-Weeks in HLA-DQ2.5+ Celiac Disease (CeD)

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S180-S180

2016

Volltextzugriff (PDF)

A11 RISK PERCEPTION AND KNOWLEDGE OF COVID-19 IN PATIENTS WITH CELIAC DISEASE

Journal of the Canadian Association of Gastroenterology, 2021-03, Vol.4 (Supplement_1), p.12-14

2021

Volltextzugriff (PDF)

A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY

Journal of the Canadian Association of Gastroenterology, 2023-03, Vol.6 (Supplement_1), p.7-8

2023

Volltextzugriff (PDF)

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

Gut, 2006-04, Vol.55 (4), p.485-491

2006

Volltextzugriff (PDF)

Antagonists and non-toxic variants of the dominant wheat qliadin T cell epitope in coeliac disease

Gut, 2006, Vol.55 (4), p.485-491

2006

Volltextzugriff (PDF)

Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an A ustralasian perspective

Internal medicine journal, 2015-04, Vol.45 (4), p.441-450

2015

Volltextzugriff (PDF)

Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective

Internal medicine journal, 2015-04, Vol.45 (4), p.441-450

2015

Volltextzugriff (PDF)

Aspiration in the context of upper gastrointestinal endoscopy

Canadian journal of gastroenterology, 2007-04, Vol.21 (4), p.223-225

2007

Volltextzugriff (PDF)

A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease

Clinical immunology (Orlando, Fla.), 2024-07, Vol.264, p.110259, Article 110259

2024

Volltextzugriff (PDF)

Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies

Frontiers in pediatrics, 2018-11, Vol.6, p.350-350

2018

Volltextzugriff (PDF)

Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease

Gut, 2020-05, Vol.69 (5), p.830-840

2020

Volltextzugriff (PDF)

Circulating gluten-specific FOXP3+ CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease

Journal of allergy and clinical immunology, 2017-12, Vol.140 (6), p.1592-1603.e8

2017

Volltextzugriff (PDF)

Consistency in Polyclonal T-cell Responses to Gluten Between Children and Adults With Celiac Disease

Gastroenterology (New York, N.Y. 1943), 2015-11, Vol.149 (6), p.1541-1552.e2

2015

Volltextzugriff (PDF)

Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity

United European gastroenterology journal, 2020-02, Vol.8 (1), p.108-118

2020

Volltextzugriff (PDF)

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

Science advances, 2019-08, Vol.5 (8), p.eaaw7756-eaaw7756

2019

Volltextzugriff (PDF)

Dissecting the T‐cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1184-1191

2010

Volltextzugriff (PDF)

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

Gastroenterology (New York, N.Y. 1943), 2016-10, Vol.151 (4), p.670-683

2016

Volltextzugriff (PDF)

Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes

Diabetes care, 2024-10, Vol.47 (10), p.1750-1756

2024

Volltextzugriff (PDF)

Editorial: a novel approach to monitor mucosal healing in coeliac disease—as simple as shifting goalposts?

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (9), p.894-895

Tye‐Din, J. A.

2017

Volltextzugriff (PDF)

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

Clinical immunology (Orlando, Fla.), 2010-03, Vol.134 (3), p.289-295

2010

Volltextzugriff (PDF)

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

The lancet. Gastroenterology & hepatology, 2023-05, Vol.8 (5), p.446-457

2023

Volltextzugriff (PDF)

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

The lancet. Gastroenterology & hepatology, 2017-07, Vol.2 (7), p.479-493

2017

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

496a - Serum IL-2 and IL-8 are Elevated within 4 h after Gluten Ingestion in Celiac Disease (CED) Patients on Gluten-Free Diet (GFD) and Potential to Resolve Indeterminate Diagnoses for Patients on GFD

846 Efficacy, Safety, Tolerability, and Immunological Effects of Nexvax2®, a Peptide-Based Therapeutic Vaccine, Administered by Intra-Dermal (ID) Injection Twice-Weekly for 8-Weeks in HLA-DQ2.5+ Celiac Disease (CeD)

A11 RISK PERCEPTION AND KNOWLEDGE OF COVID-19 IN PATIENTS WITH CELIAC DISEASE

A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

Antagonists and non-toxic variants of the dominant wheat qliadin T cell epitope in coeliac disease

Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an A ustralasian perspective

Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective

Aspiration in the context of upper gastrointestinal endoscopy

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease

Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies

Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease

Circulating gluten-specific FOXP3+ CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease

Consistency in Polyclonal T-cell Responses to Gluten Between Children and Adults With Celiac Disease

Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

Dissecting the T‐cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes

Editorial: a novel approach to monitor mucosal healing in coeliac disease—as simple as shifting goalposts?

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Suchergebnisse filtern